House Appropriation Leaders Propose Emergency Funding For FDA's Infant Formula Programs
Executive Summary
Democrats introduce bill two days before Agriculture, Rural Development, FDA and Related Agencies subcommittee will question FDA Commissioner Robert Califf about agency’s oversight of formula industry during a hearing on FY2023 budget.
You may also be interested in...
Senate Proposes Smaller Boost Than House For FDA FY2023 Appropriation
Senate Appropriations Committee proposes $1.185bn to CFSAN and $2.19bn to CDER, both levels short of House appropriators passed in June. FDA requested $30.36m in user fees from monograph drugs but no amount was specified in Senate draft bill.
House Appropriators Reject Docking FDA FY2023 Budget Until Formula Crisis Report Provided
First-term Iowa Republican Hinson had support from Democrat as well as other GOP members for withholding part of commissioner office’s FY2023 budget. Opposition from a self-acknowledged unlikely source, committee chair DeLauro, steered votes toward rejecting the proposal.
House Has Slim Boost For FDA FY2023 Spending, But Wants Slimmer Budget Document From Agency
Appropriations Committee publishes FY2023 spending bill and report FDA day before it votes on the legislation. It recommends increasing FDA’s budget by less than $400m from its current appropriation to $6.48bn.